SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
10-Q/A | Amendment to a previously filed 10-Q |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
8-K/A | Amendment to a previously filed 8-K |
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
8-K/A | Amendment to a previously filed 8-K |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
8-K/A | Amendment to a previously filed 8-K |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
8-K/A | Amendment to a previously filed 8-K |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA | |
SC TO-I/A | Amendment to a previously filed SC TO-I |
View HTML |
Displaying 31 - 40 of 958 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.